Bruker Expands Microbial ID and Outbreak Tools with Cloud, Automation, and AI
Event summary
- Bruker introduced the MBT Easy T® Kit to standardize MALDI sample prep, supporting 2,000 samples with room-temperature storage.
- MALDI Biotyper® reference libraries expanded to 5,300+ species, with 600 new additions and 30% stronger filamentous fungi coverage.
- Cloud-based MALDI identification solution (RUO) launched for expert labs, featuring curated libraries for yeasts, anaerobes, and malaria vectors.
- IR Biotyper® expanded with new classifiers for Salmonella Typhi, STEC, and Shigella to enhance outbreak management.
- Molzym acquisition strengthens culture-independent diagnostics with MolYsis™ host-DNA depletion technology.
The big picture
Bruker’s updates reflect a push toward fully automated, cloud-enabled microbial diagnostics amid rising demand for rapid outbreak response. The Molzym acquisition signals deeper investment in culture-independent sequencing, while AI and machine learning integration positions the company at the forefront of next-gen antimicrobial resistance profiling. These moves align with broader trends in precision medicine and hospital infection control.
What we're watching
- Regulatory Progress
- Whether Bruker’s FDA submissions for mycobacteria and filamentous fungi identification will succeed in 2026.
- AI Adoption
- How Bruker’s AI-driven antibiotic resistance prediction (AUROC >0.8) scales beyond Staphylococcus aureus.
- Automation Integration
- The pace at which MBT PrepMatic™ and MBT SepsiMatic® achieve IVDR compliance for clinical use.
Related topics